Adaptimmune Ther ADR (ADAP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADAP | ADCT | ZNTL | ||
| Company | Adaptimmune Ther ADR | Adc Therapeutics Sa | Zentalis Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 1.0300 | 3.17 | 3.49 | ||
| High | 1.2200 | 3.38 | 3.65 | ||
| Low | 1.0250 | 3.11 | 3.27 | ||
| Last | 1.2200 | 3.26 | 3.62 | ||
| Change | +0.2000 | +0.20 | +0.14 | ||
| % Change | +19.61% | +6.54% | +4.02% | ||
| Volume | 3,814,308 | 657,871 | 1,283,552 | ||
| 20-Day Average Volume | 1,545,030 | 1,185,703 | 2,794,428 | ||
| Previous Close | 1.0200 | 3.06 | 3.48 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 0.9837 | 3.08 | 6.45 | ||
| 20-Day Raw Stochastic | 100.00% | 63.27% | 4.05% | ||
| 20-Day Relative Strength | 60.50% | 47.85% | 23.15% | ||
| Weighted Alpha | -13.06 | -9.29 | -77.95 | ||
| Today's Opinion | 16% Buy | Hold | 100% Sell | ||
| Previous Opinion | 8% Sell | 16% Sell | 100% Sell | ||
| Last Month's Opinion | 8% Sell | 8% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +24.39% since 06/27/24 | +16.01% since 06/27/24 | -13.81% since 06/27/24 | ||
| Low | 0.9601 on 06/28/24 | 2.85 on 06/28/24 | 3.27 on 07/05/24 | ||
| High | 1.2200 on 07/05/24 | 3.72 on 07/02/24 | 4.26 on 07/01/24 | ||
| 1-Month | |||||
| %Chg | +15.09% since 06/05/24 | -7.91% since 06/05/24 | -68.93% since 06/05/24 | ||
| Low | 0.8250 on 06/26/24 | 2.45 on 06/26/24 | 3.27 on 07/05/24 | ||
| High | 1.2200 on 07/05/24 | 3.73 on 06/07/24 | 11.91 on 06/06/24 | ||
| 3-Month | |||||
| %Chg | -10.95% since 04/05/24 | -34.80% since 04/05/24 | -75.99% since 04/05/24 | ||
| Low | 0.8250 on 06/26/24 | 2.45 on 06/26/24 | 3.27 on 07/05/24 | ||
| High | 1.4100 on 04/08/24 | 5.38 on 04/08/24 | 15.79 on 04/09/24 | ||
| 6-Month | |||||
| %Chg | +38.64% since 01/05/24 | +60.59% since 01/05/24 | -76.48% since 01/05/24 | ||
| Low | 0.6517 on 01/17/24 | 1.71 on 01/19/24 | 3.27 on 07/05/24 | ||
| High | 2.0500 on 03/08/24 | 6.04 on 02/20/24 | 18.07 on 02/28/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 251,761 | 253,298 | 247,170 | ||
| Shares Outstanding, K | 246,825 | 82,777 | 71,026 | ||
| Annual Sales | 60,280,000 | 69,560,000 | 0 | ||
| Annual Net Income | -113,870,000 | -240,050,000 | -292,190,000 | ||
| Last Quarter Sales | 5,680,000 | 18,050,000 | 40,560,000 | ||
| Last Quarter Net Income | -48,500,000 | -46,610,000 | 10,070,000 | ||
| 60-Month Beta | 2.31 | 1.59 | 1.70 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.18 on 05/15/24 | -0.56 on 05/06/24 | 0.14 on 05/07/24 | ||
| Latest Earnings Date | 08/14/24 | 08/13/24 | 08/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||